Sutro Biopharma Statistics
NASDAQ: STROHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
14.66+0.21 (+1.45%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 14.66 0.00%
Sutro Biopharma by the numbers
Sutro Biopharma has a market capitalization of $243.1 million based on 16.58M shares outstanding. With trailing EPS of $-17.28, Sutro Biopharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 26.1% below its 50-day average and 36.3% below its 200-day average.
Average daily trading volume is 289.73K shares, or about $4.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
STRO valuation vs. peer median
| Metric | STRO | Peer median | Difference |
|---|---|---|---|
| Market cap | $243.08M | $235.72M | +3% |
| Avg. volume | 289.73K | 1.52M | -81% |
Peer median across 8 companies: LCTX, IPSC, FATE, PALI, PLX, SABS, IVVD, ALEC.
Valuation
- Market cap
- $243.08M
- EPS (TTM)
- $-17.28
- Shares outstanding
- 16.58M
Price and trading
- Previous close
- 14.45
- Open
- 14.24
- Day range
- 14.01 – 15.73
- 52-week range
- 7.15 – 43.85
- 52-week change
- +74.52%
- Beta
- —
- Volume
- 232.53K
- Average volume
- 289.73K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 243.08M
- Forward Pe
- -2.36
- Eps
- -17.28
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 43.85
- Week52 Low
- 7.15
- Avg Volume
- 289.73K
- Shares Outstanding
- 16.58M
- Ma50
- 19.84
- Ma200
- 23.03
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -66.57%
- Pct From52w Low
- 105.03%